AHF on New 340B Report: ‘Bought and Paid for by Big Drug Companies!’

AHF steps up criticism of Congressional leadership for buying into Pharma’s false narrative on the 340B program—a federally-administered drug discount pricing program that costs the… Read more

AHF Blasts New House Committee Report on 340B Drug Discount Program: ‘A Solution in Search of a Problem’

AHF criticizes Congressional leadership for buying into Pharma’s false narrative on the 340B program—a federally-administered drug discount program that costs the government and taxpayers nothing,… Read more

Congressman Scott Peters (D-CA) Gets Thanks from Drug Industry for Reckless Bill Gutting Drug Discounts

Peters curries favor with Big Pharma by co-sponsoring a bill (H.R. 4710) that strangles nonprofit hospitals with useless red tape, forcing many to forgo participating… Read more

LA Blade: AHF highlights ‘social justice’ in Rose Parade (VIDEO)

January 2, 2018 by Karen Ocamb The theme of New Year Day’s 129th Rose Parade was “making a difference,” reminding the US and international audience that… Read more

AHF: Congenital Syphilis a Growing Crisis; CDC Must Act Aggressively on Prevention, Treatment

 The number of cases of congenital syphilis—mother to child transmission before or during birth—in 2015 (487 cases) is the highest it has been since 2001… Read more

AROUND THE GLOBE

AHF Urges G20 to Increase Financial Commitment and Global HIV Response in Light of Summit in Hamburg

HAMBURG (6 July 2017) During Germany’s presidency of the G20, for the first time, the issue of global health has been placed on the G20… Read more


More News

View Photos of Our Advocacy Efforts